Settings

Sidenav Mini

Light/Dark

Money Thursday June 23rd 2022 Morning Stock Newsletter

🌟Goooooooood morning Team and Happy Money Thursday🌟 

WELCOME BACK to the WORLD’S BEST Trading Chatroom! I hope you all had a wonderful evening and that you are ready for today’s trading session. 

The market has been a little off this week as we have seen pretty choppy/inconsistent market conditions. This is a part of trading and we cannot expect the market to always be on fire. We simply have to assess and adapt to take advantage of what we have!

Everyone is doing fantastic so keep up the amazing work and lets attack this day!

Live Stream is now up and Live Trade Commentary will begin at 8:50AM. πŸš€ πŸ‘ πŸ“ˆ πŸ”₯

Get πŸ”₯ FIRED πŸ”₯up team because we are hitting it hard today.


STOCKS WITH NEWS

Stock futures gain as market attempts to rebound from 2022 sell-off https://www.cnbc.com/2022/06/22/stock-futures-are-little-changed-after-major-averages-dip-investors-mull-slowdown.html

$NIO $LI – Chinese EV stocks jump as State Council keeps tax cuts in place https://seekingalpha.com/news/3851095-chinese-ev-stocks-jump-as-state-council-keeps-tax-cuts-in-place

$BOXD – JUNE 7th NEWS – Boxed (NYSE:BOXD) will be added to the Russell 2000 Index, effective June 27, 2022, according to a preliminary list of additions posted by FTSE Russell on June 3, 2022.

$SIGA, $CODX – Monekeypox plays tick higher ahead of WHO emergency meeting

$BHAT – Blue Hat Interactive Entertainment Technology Terminates Its Previously Proposed Shelf Takedown Offering

$RDHL – RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22

$SNGX – Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine

$FSTX – Sino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million >FSTX BZ: F-star Therapeutics Shares To Resume Trade At 8:00 a.m. ET

$SNOW – JPMorgan Upgrades Snowflake to Overweight From Neutral, Price Target at $165

$SMFL – EXCLUSIVE: Smart for Life Accelerates Manufacturing Of Milk Dust Lactation Products Amid Baby Formula Shortage

$CNSP – CNS Pharmaceuticals Receives Approval from U.S. FDA for Protocol Amendment to Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM

My top stocks for the day


PRE MARKET GAPPERS


PRIOR DAY TOP GAINERS


Earnings this Week